Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.virusres.2020.198057 http://scihub22266oqcxt.onion/10.1016/j.virusres.2020.198057 32531236!7282797!32531236     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Virus+Res 2020 ; 286 (ä): 198057 Nephropedia Template TP {{tp|p=32531236|t=2020. Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China |pdf=|usr=}}{{32531236}} gab.com Text Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China JO: Virus Res http://www.kidney.de/pget.php?&tw=1&pmid=32531236 #FOAvip The fight against the novel coronavirus pneumonia (namely COVID-19) that seriously harms human health is a common task for all mankind. Currently, development of drugs against the novel coronavirus (namely SARS-CoV-2) is quite urgent. Chinese medical workers and scientific researchers have found some drugs to play potential therapeutic effects on COVID-19 at the cellular level or in preliminary clinical trials. However, more fundamental studies and large sample clinical trials need to be done to ensure the efficacy and safety of these drugs. The adoption of these drugs without further testing must be careful. The relevant articles, news, and government reports published on the official and Preprint websites, PubMed and China National Knowledge Infrastructure (CNKI) databases from December 2019 to April 2020 were searched and manually filtered. The general pharmacological characteristics, indications, adverse reactions, general usage, and especially current status of the treatment of COVID-19 of those potentially effective drugs, including chemical drugs, traditional Chinese medicines (TCMs), and biological products in China were summarized in this review to guide reasonable medication and the development of specific drugs for the treatment of COVID-19. Twit Text FOAVip Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China ????Virus Res http://www.kidney.de/pget.php?&tw=1&pmid=32531236 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32531236 #FOAvip English Wikipedia <ref>{{Cite pmid|32531236}}</ref> Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China #MMPMID32531236 Pan X; Dong L; Yang L; Chen D; Peng C Virus Res 2020[Sep]; 286 (ä): 198057 PMID32531236show ga The fight against the novel coronavirus pneumonia (namely COVID-19) that seriously harms human health is a common task for all mankind. Currently, development of drugs against the novel coronavirus (namely SARS-CoV-2) is quite urgent. Chinese medical workers and scientific researchers have found some drugs to play potential therapeutic effects on COVID-19 at the cellular level or in preliminary clinical trials. However, more fundamental studies and large sample clinical trials need to be done to ensure the efficacy and safety of these drugs. The adoption of these drugs without further testing must be careful. The relevant articles, news, and government reports published on the official and Preprint websites, PubMed and China National Knowledge Infrastructure (CNKI) databases from December 2019 to April 2020 were searched and manually filtered. The general pharmacological characteristics, indications, adverse reactions, general usage, and especially current status of the treatment of COVID-19 of those potentially effective drugs, including chemical drugs, traditional Chinese medicines (TCMs), and biological products in China were summarized in this review to guide reasonable medication and the development of specific drugs for the treatment of COVID-19. |*Pandemics[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Amides/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*drug effects/immunology[MESH] |COVID-19[MESH] |China/epidemiology[MESH] |Chloroquine/therapeutic use[MESH] |Coronavirus Infections/*drug therapy/*epidemiology/mortality/virology[MESH] |Drug Combinations[MESH] |Drugs, Chinese Herbal/*therapeutic use[MESH] |Humans[MESH] |Indoles/therapeutic use[MESH] |Interferons/therapeutic use[MESH] |Lopinavir/therapeutic use[MESH] |Lung/drug effects/pathology/virology[MESH] |Pneumonia, Viral/*drug therapy/*epidemiology/mortality/virology[MESH] |Pyrazines/therapeutic use[MESH] |Ribavirin/therapeutic use[MESH] |Ritonavir/therapeutic use[MESH] |SARS-CoV-2[MESH]Potential drugs for the treatment of the novel coronavirus pneumonia ((epmc).pdf DeepDyve Pubget Overpricing